John H. Sampson, MD, PhD, MBA, MHSc, discusses results from cohort 1 of the CHECKMATE-143 trial.
John H. Sampson, MD, PhD, MBA, MHSc
Advertisement
Articles by John H. Sampson, MD, PhD, MBA, MHSc
Advertisement
Latest Updated Articles
Dr. Sampson on Nivolumab Monotherapy for Recurrent GlioblastomaNovember 20th 2015
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Camizestrant Plus a CDK4/6 Inhibitor for Emergent ESR1-Mutated HR+, HER2– Advanced Breast Cancer
2
Ivonescimab Meets OS End Point vs Pembrolizumab in First-Line PD-L1+ NSCLC
3
Daraxonrasib Yields Durable Responses in Previously Treated RAS-Mutant NSCLC
4
Novel Analysis Reveals Millions of Life-Years Saved by Blood Cancer Treatments
5